Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Genetics and Genomics of Sars-Cov-2: A Review of the Literature With the Special Focus on Genetic Diversity and Sars-Cov-2 Genome Detection Publisher Pubmed



Rahimi A1 ; Mirzazadeh A2, 3 ; Tavakolpour S4
Authors

Source: Genomics Published:2021


Abstract

The outbreak of 2019-novel coronavirus disease (COVID-19), caused by SARS-CoV-2, started in late 2019; in a short time, it has spread rapidly all over the world. Although some possible antiviral and anti-inflammatory medications are available, thousands of people are dying daily. Well-understanding of the SARS-CoV-2 genome is not only essential for the development of new treatments/vaccines, but it also can be used for improving the sensitivity and specificity of current approaches for virus detection. Accordingly, we reviewed the most critical findings related to the genetics of the SARS-CoV-2, with a specific focus on genetic diversity and reported mutations, molecular-based diagnosis assays, using interfering RNA technology for the treatment of patients, and genetic-related vaccination strategies. Additionally, considering the unanswered questions or uncertainties in these regards, different topics were discussed. © 2020 Elsevier Inc.
Related Docs
View other Related Docs
1. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
2. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
3. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
Experts (# of related papers)
View all Related Experts
Shahrzad Ahangarzadeh (2)
Shaghayegh Haghjooy Javanmard (2)
Other Related Docs
4. Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19, Infezioni in Medicina (2020)
5. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
6. An Updated Review of the Association of Host Genetic Factors With Susceptibility and Resistance to Covid-19, Journal of Cellular Physiology (2021)
7. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
8. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
9. An Overview on the Genomic Characteristics of the New Coronavirus (2019-Ncov) and the Prospective in Pathogenesis and Treatment of Covid-19 Infection, Journal of Isfahan Medical School (2020)
10. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
11. Human Viral Pathogens in the Wastewater-Source Water-Drinking Water Continuum: Evidence, Health Risks, and Lessons for Future Outbreaks in Low-Income Settings, Science of the Total Environment (2024)
12. Immune and Bioinformatics Identification of T Cell and B Cell Epitopes in the Protein Structure of Sars-Cov-2: A Systematic Review, International Immunopharmacology (2020)
13. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
14. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
15. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
16. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
17. Covid-19 Pandemic: Insights Into Genetic Susceptibility to Sars-Cov-2 and Host Genes Implications on Virus Spread, Disease Severity and Outcomes, Human Antibodies (2022)
18. Comparison of Omicron and Delta Variants of Sars-Cov-2: A Systematic Review of Current Evidence, Infectious Disorders - Drug Targets (2024)
19. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
20. Chitin and Chitosan As Tools to Combat Covid-19: A Triple Approach, International Journal of Biological Macromolecules (2021)